DOPS Adjuvant Confers Enhanced Protection Against Malaria for VLP-TRAP Based Vaccines

Diseases
doi 10.3390/diseases6040107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Synthetic Peptide Vaccine Confers Protection Against Murine Malaria

Journal of Experimental Medicine
MedicineAllergyImmunology
1987English

New Approaches to VLP-based Vaccines

Microbiology Australia
Applied MicrobiologyPublic HealthMicrobiologyEnvironmentalBiotechnologyOccupational Health
2017English

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection Against Tuberculosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2018English

Correlates of Protection for M Protein-Based Vaccines Against Group a Streptococcus

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Enhanced Protection Against Malaria by a Chimeric Merozoite Surface Protein Vaccine

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

Genome Based Vaccines Against Parasites

2011English

Measles Vaccines May Provide Partial Protection Against COVID-19

International Journal of Cancer and Biomedical Research
2020English

Experimental Syphilis Vaccines in Rabbits. I. Differential Protection With an Adjuvant Spectrum.

Sexually Transmitted Infections
DermatologyInfectious Diseases
1976English

Mannose-Binding Protein B Allele Confers Protection Against Tuberculous Meningitis

Pediatric Research
Child HealthPediatricsPerinatology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy